Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations 12-08-2025, 12:00

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed 21-09-2025, 09:15

CGTN: Two years on, China's Global Civilization Initiative gains greater relevance in a turbulent world 15-03-2025, 20:01